Indobufen may serve as an alternative antiplatelet therapy for acute myocardial infarction patients with high bleeding risk or aspirin intolerance.
Does indobufen improve efficacy and safety compared to aspirin in patients with acute myocardial infarction?
Indobufen may serve as a viable alternative antiplatelet therapy for AMI patients who have a high bleeding risk or cannot tolerate aspirin.
Absolute Event Rate: 0% vs 0%
Indobufen may be considered an alternative antiplatelet therapy for AMI patients with a high bleeding risk and/or aspirin intolerance/hypersensitivity, however, prospective studies are needed to confirm these findings.
Sasmita et al. (Mon,) reported a other. Indobufen may serve as an alternative antiplatelet therapy for acute myocardial infarction patients with high bleeding risk or aspirin intolerance.